🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Status
Withdrawn
Location
NL-Amsterdam-VUMC
Start Date
2022-01
Trial ID
NCT05063123
Treatments Being Tested
The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-03-21
Trial ID
NCT05015426
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled clinical trial of Fe...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2019-09-09
Trial ID
NCT03678493
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
The researchers are doing this study to compare 2 different GVHD prevention...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2026-01-20
Trial ID
NCT07359859
Treatments Being Tested
Given the role of B cells in the pathophysiology of chronic graft versus ho...
Status
Withdrawn
Location
Department of Hematology, Nanfang Hospital, Southern Medical University,
Start Date
2022-01-01
Trial ID
NCT05604742
Treatments Being Tested
This phase II trial tests how well ibrutinib works in preventing chronic gr...
Status
Terminated
Location
Mayo Clinic in Florida
Start Date
2024-12-13
Trial ID
NCT06271616
Treatments Being Tested
This is a prospective, open-label, nonrandomized, prospective clinical tria...
Status
Completed
Location
Children's Hospital of Alabama/UAB
Start Date
2013-09
Trial ID
NCT01772953
Treatments Being Tested
This is a phase II, open-label, non-randomized, prospective study of haploi...
Status
Enrolling By Invitation
Location
Children's Hospital Los Angeles
Start Date
2015-10
Trial ID
NCT02646839
Treatments Being Tested
The goal of this clinical trial is to test BSB-1001 which is a new type of ...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-02-04
Trial ID
NCT06704152
Treatments Being Tested